Geoffrey Glass
About Geoffrey Glass
Geoffrey Glass Founding CEO
Geoffrey Glass is the Founding CEO, with an extensive career spanning over 25 years in leading services and therapeutic companies within the Life Sciences sector. His experience includes a range of high-level executive roles and significant contributions to multiple organizations where he has led key business areas and helped drive strategic growth.
Geoffrey Glass Education and Expertise
Geoffrey Glass' career began at Ernst & Young (EY) within their consulting practice. Over nearly a decade at EY, he managed major accounts and led various practice areas. His background in consulting provided him with strong expertise in business strategy, corporate development, and leading complex projects, which he later applied to roles in Life Sciences and pharmaceuticals.
Geoffrey Glass at Valeant Pharmaceuticals
Geoffrey Glass served on the executive team at Valeant Pharmaceuticals, now known as Bausch Health, for nearly five years. Initially, he held the position of Chief Information Officer (CIO) before advancing to oversee the company's Asia business operations. During his tenure, Glass played an instrumental role in steering the company's strategic initiatives and driving performance in the Asian market.
Geoffrey Glass Leadership at Patheon
At Patheon, Geoffrey Glass was recruited to assist in the company's turnaround efforts. Over his seven-year period at Patheon, Glass held leadership positions across various key functions including Strategy, Corporate Development, Sales, Marketing, Pricing, and Contracting. His tenure culminated with his role as President of the Banner Life Sciences division, where he helped streamline operations and drive significant growth.
Geoffrey Glass Chairman of Avadel Pharmaceuticals
Currently, Geoffrey Glass serves as the Chairman of Avadel Pharmaceuticals (NASDAQ: AVDL). In this role, he oversees the company's strategic direction and governance, working closely with the executive team and the board to guide Avadel Pharmaceuticals in its mission to develop and bring to market innovative therapeutic solutions.